A new study published in Clinical Infectious Diseases highlights the potential of pemivibart, a long-acting monoclonal ...

The global monoclonal antibodies in veterinary health market size was US$ 671.6 million in 2021. The global monoclonal antibodies in veterinary health market are expected to grow to US$ 2371.1 million ...

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

The first paper from a multi-year clinical research study has been published in The Lancet Infectious Diseases. The article ...

Note that some links may require registration or subscription. HHS Secretary Robert F. Kennedy Jr. announced that 22 projects ...

The first paper from a multi-year clinical research study has been published in The Lancet Infectious Diseases: Dynamics of ...

COVID-19 prevention methods such as masking and social distancing also suppressed the circulation of common respiratory diseases, leaving young ...

Pfizer is the closest company to producing a Lyme disease vaccine. Experts are concerned that vaccine skepticism could stand in its way.

For infants born from October to February, maternal vaccination was cost-effective, but compared with vaccination, nirsevimab ...

FDA expands tocilizumab-anoh's indication for treating cytokine release syndrome, enhancing treatment options for patients ...